Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study

Keyphrases

• Prospective Cohort Study 100%
• Transplacental Antibody Transfer 100%
• Third Trimester 100%
• Severe Acute Respiratory Syndrome coronavirus-2 Vaccine 100%
• COVID-19 50%
• Early-late 50%
• Receptor-binding Domain 50%
• Vaccination 37%
• Immunization 37%
• Placental Transfer 37%
• Serum IgE 37%
• Antireceptor 37%
• First Dose 25%
• Transfer Ratio 25%
• Maternal Blood 25%
• Anti-S 25%
• Neutralizing Antibodies 25%
• Gestational Age 12%
• BNT162b2 12%
• Vaccine Dose 12%
• IgG Levels 12%
• Vaccination in Pregnancy 12%
• Cord Blood Serum 12%
• Week of Gestation 12%
• Paired Serum 12%
• IgG Concentration 12%
• Protein Receptor 12%
• MRNA Vaccine 12%
• Trimester 12%
• S-ratio 12%
• Term Delivery 12%
• Spike Protein 12%
• Cord Blood Sample 12%
• Seroprotection 12%

Medicine and Dentistry

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Prospective Cohort Study 100%
• Third Trimester Pregnancy 100%
• Passive Immunization 100%
• Receptor Binding 50%
• Placental Transfer 37%
• Cord Blood 25%
• Neutralizing Antibody 25%
• Maternal Blood 25%
• Cohort Analysis 12%
• Pregnancy 12%
• First Trimester Pregnancy 12%
• Protein S 12%
• Obstetric Delivery 12%
• Messenger RNA 12%
• Gestational Age 12%

Immunology and Microbiology

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• Third Trimester Pregnancy 100%
• Immunology 100%
• Receptor Binding 50%
• Placental Transfer 37%
• Neutralizing Antibody 25%
• Spike 12%
• First Trimester Pregnancy 12%
• Pregnancy 12%
• Serum (Blood) 12%